Search
for
Sort by
Research 151–180 of 1000+
- Acute and Long-term Toxicity of Cyclophosphamide
- Intralesional therapy for the treatment of keratoacanthoma
- Fibrotic enzymes modulate wound‐induced skin tumorigenesis
- Case Study: Hereditary Cancer Genetic Testing in Unaffected Patients May Allow for Early Intervention and Aggressive Management
- Dissecting cellulitis of the scalp successfully treated with infliximab
- The evaluation and management of hirsutism*1
- Androgenic Alopecia
- Hirsutism
- The Evaluation and Management of Hirsutism
- Dermatologic Diseases
- Anti-Androgens
- Targeting Pharmacological and Nanotechnology Based Therapeutics for Management of Hirsutism: A Comprehensive State-of-the-Art
- Hirsutism
- Alopecia areata as another immune‐mediated disease developed in patients treated with tumour necrosis factor‐α blocker agents
- Recurrence of Alopecia Areata in a Patient Receiving Etanercept Injections
- Advanced Diagnostic Approaches and Current Medical Management of Insulinomas and Adrenocortical Disease in Ferrets (Mustela putorius furo)
- A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab
- Surgical treatment of pilomatrix carcinoma: a systematic review
- Cytokines
- CLINICAL-MORPHOLOGICAL FEATURES AND NEW ASPECTS OF KERATOACANTHOMA TREATMENT:NARRATIVE REVIEW
- Editors’ Picks
- Hair loss in the elderly
- Hair Disorders
- Manganese-Doped Calcium Silicate Nanowire Composite Hydrogels for Melanoma Treatment and Wound Healing
- Biological therapy in the treatment of melanoma
- Nature-skin-based multi-responsive controlled-release electroactive scaffolds for integrated melanoma postoperative relapse prevention and wound therapy
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications